|
Name |
Caspicaiene
|
Molecular Formula | C27H34O9 | |
IUPAC Name* |
(15-acetyloxy-13-hydroxy-9,9,14,16,19-pentamethyl-18-methylidene-4,10-dioxo-5,6-dioxapentacyclo[12.6.0.01,7.03,16.09,14]icos-11-en-8-yl)acetate
|
|
SMILES |
C=C1CC23C4OOC(=O)C2C1(C)C(OC(C)=O)C(O)C3(C)C1(C)C=CC(=O)C(C)(C)C1C4OC(C)=O
|
|
InChI |
InChI=1S/C27H34O9/c1-12-11-27-18-22(32)36-35-20(27)16(33-13(2)28)17-23(4,5)15(30)9-10-24(17,6)26(27,8)19(31)21(25(12,18)7)34-14(3)29/h9-10,16-21,31H,1,11H2,2-8H3/t16-,17?,18?,19?,20?,21+,24-,25?,26-,27?/m1/s1
|
|
InChIKey |
KUVWFENIBLGCNF-APKODVJJSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 502.56 | ALogp: | 2.5 |
HBD: | 1 | HBA: | 9 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 125.4 | Aromatic Rings: | 5 |
Heavy Atoms: | 36 | QED Weighted: | 0.344 |
Caco-2 Permeability: | -5.302 | MDCK Permeability: | 0.00002520 |
Pgp-inhibitor: | 0.997 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.857 | 20% Bioavailability (F20%): | 0.943 |
30% Bioavailability (F30%): | 0.213 |
Blood-Brain-Barrier Penetration (BBB): | 0.732 | Plasma Protein Binding (PPB): | 40.42% |
Volume Distribution (VD): | 0.583 | Fu: | 56.66% |
CYP1A2-inhibitor: | 0.008 | CYP1A2-substrate: | 0.121 |
CYP2C19-inhibitor: | 0.021 | CYP2C19-substrate: | 0.706 |
CYP2C9-inhibitor: | 0.023 | CYP2C9-substrate: | 0.057 |
CYP2D6-inhibitor: | 0.04 | CYP2D6-substrate: | 0.069 |
CYP3A4-inhibitor: | 0.612 | CYP3A4-substrate: | 0.475 |
Clearance (CL): | 3.237 | Half-life (T1/2): | 0.036 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.118 |
Drug-inuced Liver Injury (DILI): | 0.098 | AMES Toxicity: | 0.036 |
Rat Oral Acute Toxicity: | 0.957 | Maximum Recommended Daily Dose: | 0.886 |
Skin Sensitization: | 0.021 | Carcinogencity: | 0.397 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.024 |
Respiratory Toxicity: | 0.959 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005316 | 0.349 | D0H2MO | 0.329 | ||||
ENC003179 | 0.349 | D03ZZK | 0.277 | ||||
ENC003159 | 0.349 | D0G7KJ | 0.270 | ||||
ENC004311 | 0.344 | D0OL7F | 0.260 | ||||
ENC003163 | 0.322 | D09SIK | 0.250 | ||||
ENC002259 | 0.316 | D08BDT | 0.245 | ||||
ENC006041 | 0.314 | D09WYX | 0.245 | ||||
ENC003776 | 0.314 | D0E9KA | 0.238 | ||||
ENC005315 | 0.313 | D02QJH | 0.231 | ||||
ENC005188 | 0.308 | D01ZOG | 0.231 |